Dr. Elise Caroline Williams, AUD, CCC-A Audiologist Medicare: Accepting Medicare Assignments Practice Location: 19600 E Ross St, Tahlequah, OK 74464 Phone: 539-234-3456 |
Miss Virginia Lee Hays, MS CCC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 5700 Arnold St, 72nd Mdg/sgpoa, Tinker Afb, OK 73145 Phone: 405-734-3309 |
Dr. Stephanie Brushett, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 8941 Entrance Road A, Bldg 3334, Rm 125, Tinker Afb, OK 73145 Phone: 405-582-6822 |
Allison P Finch, M.S.,CCC-A Audiologist Medicare: Accepting Medicare Assignments Practice Location: 6802 S Olympia Ave Ste 200, Tulsa, OK 74132 Phone: 918-388-9740 Fax: 918-388-9741 |
Jensen James, AU.D. Audiologist Medicare: Medicare Enrolled Practice Location: 5350 E 31st St Ste 301, Tulsa, OK 74135 Phone: 918-392-7600 Fax: 405-548-4349 |
Audiology Of Tulsa Inc Audiologist Medicare: Not Enrolled in Medicare Practice Location: 4564 S Harvard Ave, Ste A, Tulsa, OK 74135 Phone: 918-745-9052 Fax: 918-749-9770 |
Erin Buchanan, AUD Audiologist Medicare: Accepting Medicare Assignments Practice Location: 6475 S Yale Ave Ste 401, Tulsa, OK 74136 Phone: 918-502-9555 Fax: 918-502-9559 |
Karen Fernow, AU.D Audiologist Medicare: Accepting Medicare Assignments Practice Location: 3105 S Harvard Ave, Tulsa, OK 74135 Phone: 918-508-7601 Fax: 918-508-7603 |
Grace Holderman, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 5350 E 31st St Ste 301, Tulsa, OK 74135 Phone: 918-392-7600 Fax: 405-548-4350 |
Ms. Julia A Shirk, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1145 S Utica Ave, Suite 302, Tulsa, OK 74104 Phone: 918-592-3737 Fax: 918-592-3337 |
Dr. Vikki J Duke, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 4564 S Harvard Ave, Suite A, Tulsa, OK 74135 Phone: 918-745-9052 Fax: 918-749-9770 |
Barbra S Morykwas, AU.D. Audiologist Medicare: Medicare Enrolled Practice Location: 6802 S Olympia Ave Ste 200, Tulsa, OK 74132 Phone: 918-388-9090 Fax: 918-388-9741 |
Karen Cox, M.S. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 5020 E 68th St, Tulsa, OK 74136 Phone: 918-492-3636 Fax: 918-494-8915 |
Marcella Strickland, AUD Audiologist Medicare: Accepting Medicare Assignments Practice Location: 5020 E 68th St, Tulsa, OK 74136 Phone: 918-492-3636 Fax: 918-494-8915 |
Mrs. Kristyn Michelle Dixon, AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 3105 S Harvard Ave, Tulsa, OK 74135 Phone: 918-508-7601 Fax: 918-508-7603 |
Vicki Fisher, M.S. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 6475 S Yale Ave Ste 401, Tulsa, OK 74136 Phone: 918-502-9555 Fax: 918-502-9559 |
Dr. Jessenia Pilar Ramirez, AUD Audiologist Medicare: Medicare Enrolled Practice Location: 5020 E 68th St, Tulsa, OK 74136 Phone: 918-492-3636 |
Dr. Blair Kathryn Downey, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 9202 S Toledo Ave, Tulsa, OK 74137 Phone: 918-493-3133 Fax: 918-493-2322 |
Stacy Lackey, M.S. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 5635 N Martin Luther King Jr Blvd, Tulsa, OK 74126 Phone: 918-594-4731 Fax: 918-595-4269 |
Gail Marie Evans, CCC Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1725 E 19th St Ste 100, Tulsa, OK 74104 Phone: 918-742-7376 Fax: 918-743-2117 |
News Archive
As the coronavirus disease (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), wreaks havoc across the globe, the efficacy of available vaccines is being threatened by emerging variants.
Study results by faculty members of the University of Texas School of Public Health at Houston suggests that the older, cheaper diuretics remain the drug of choice for both black and non-black patients in treating high blood pressure and reducing risk of heart disease, and confirms earlier findings that diuretics rather than newer, more expensive drugs such as ACE inhibitors, calcium channel blockers, or beta blockers should be preferred as a first therapy for most patients.
Researchers conducted a study on COVID-19 convalescent patients and post-vaccinated populations to identify the minimal levels of antibody required to protect against SARS-CoV-2 infection.
Teva Pharmaceutical Industries Ltd. and Active Biotech today announced the presentation of Phase III clinical and pre-clinical data, which collectively demonstrate that once-daily oral laquinimod modulates the pathological processes of multiple sclerosis to impact disease activity, disability progression and brain volume loss.
› Verified 3 days ago